Clinical Trials Sponsored by Imaxio

Total 281 results

Imaxio

Completed

Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine (SPT-001)

Leptospirosis

France
University of Oxford
Imaxio

Completed

Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults

Tuberculosis (TB)

United Kingdom
Massimo Imazio

Completed

AnakInRa for Treatment of Recurrent Idiopathic Pericarditis (AIRTRIP) (AIR TRIP)

Idiopathic Recurrent Pericarditis

Italy
neuroloop GmbH
MAXIS GmbH

Terminated

The Baroloop Study

Hypertension

Netherlands
Protembis GmbH
MAXIS, LLC

Completed

The PROTEMBO SF Trial

Aortic Stenosis

Latvia, Ireland
Peter C. Amadio, M.D.

Recruiting

A Study of Fisetin to Treat Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

United States
Mario Ammirati

Withdrawn

The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy

Hypertension

United States
Consorzio Mario Negri Sud
LifeScan

Completed

Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving Insulin (ROSES)

Type 2 Diabetes

Italy
Protembis GmbH
MAXIS Medical, LLC

Completed

The PROTEMBO C Trial

Valvular Heart Disease

Germany, Poland, Latvia
Hemovent GmbH
MAXIS Medical, LLC

Active, not recruiting

A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System of Cardiac and Respiratory Support: The MOBYBOX Trial

Respiratory Failure | Cardiac Failure | Cardio-Respiratory Failure

Germany
AIDAR Health, Inc.
MAXIS, LLC

Withdrawn

AIDI - Research & Development of a Multisensor-Based Machine Learning Technology for Real-Time Automated Detection of COVID-19 Decompensation (AIDI)

Sars-CoV-2 Infection

United States
Edward Messing
Imagin Medical

Completed

Near Infrared Fluorescence Imaging for Bladder Cancer Detection

Bladder Cancer

United States
Mario Negri Institute for Pharmacological Research

Not yet recruiting

1 vs 7 RATG Infusions in Renal Transplantation (ONSET)

Kidney Replacement

Italy
Mario Negri Institute for Pharmacological Research

Not yet recruiting

An Outcome Analysis of Primary Membranous Nephropathy (PROMENADE)

Membranous Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

New Analytic Tools for aHUS and C3G Diagnosis (COMPRare)

Healthy | Hemolytic-Uremic Syndrome | Membranoproliferative Glomerulonephritis

Italy
Mario Widmer

Recruiting

Effectiveness of a Powered Exoskeleton Combined With FES for Patients With Chronic SCI: a RCT (Ekso-FES)

Spinal Cord Injuries | Gait Disorders, Neurologic

Switzerland
Mario Negri Institute for Pharmacological Research

Recruiting

Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care

Brain Injuries, Acute

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer (ATRA)

Breast Neoplasm Female

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Autoreactive B Cells in Membranous Nephropathy (PEPTIDE)

Membranous Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study. (CHECK)

Colorectal Neoplasms

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (Fondazione IRCCS Ca' Granda Ospedale Maggione Policlinico)

Emergency Department | Evaluation | Quality of Care | Appropriateness

Italy
Mario Boccadoro

Active, not recruiting

STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS

Multiple Myeloma

Italy
Mario Negri Institute for Pharmacological Research

Completed

Diadem to Investigate the Activity and Safety of Durvalumab (Diadem)

Pleura Mesothelioma

Italy
Mario Negri Institute for Pharmacological Research

Completed

Early CPAP in COVID-19 Patients With Respiratory Failure. (EC-COVID-RCT)

COVID-19 | Emergency Departments | CPAP Ventilation

Italy
Mario Negri Institute for Pharmacological Research

Completed

Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study. (EC-COVID-PCS)

Early CPAP Ventilation in COVID-19 Patients

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation (RAFTING)

Rheumatoid Arthritis

Italy
Mario Negri Institute for Pharmacological Research

Completed

Nephrolithiasis Prevention by Lemon Juice (LIMONE)

Nephrolithiasis

Italy
Mario Negri Institute for Pharmacological Research

Terminated

the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment (VICTOR3)

Triple Negative Breast Cancer

Spain, Italy, Portugal
Mario Negri Institute for Pharmacological Research

Completed

GREAT - Good Response With Appropriate Treatment

Neoplasms | Cancer Pain

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Italy
Mario Negri Institute for Pharmacological Research

Completed

Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)

Type 2 Diabetes

Italy, Slovenia
Mario Negri Institute for Pharmacological Research

Terminated

ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach) (ITACA-S2)

Gastric Adenocarcinoma

Italy
Mario Negri Institute for Pharmacological Research

Completed

CE-US in Renal Transplantation

Renal Transplantation

Italy
Mario Negri Institute for Pharmacological Research

Completed

Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study (ALADIN)

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Italy
Consorzio Mario Negri Sud
Sanofi; LifeScan

Unknown

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice (DID3)

Type 1 Diabetes

Italy
Mario Negri Institute for Pharmacological Research

Completed

Ezetimibe and Simvastatin in Dyslipidemia of Diabetes

Type 2 Diabetes

Italy
Mario Negri Institute for Pharmacological Research

Completed

L-Arginine in Pre-Eclampsia

Pre-Eclampsia

Italy
Mario Negri Institute for Pharmacological Research

Completed

Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation

Kidney Transplant

Italy
Mario Negri Institute for Pharmacological Research

Not yet recruiting

Kidney Perfusion With or Without Absorption (POWER)

Kidney Replacement

Italy
Mario Negri Institute for Pharmacological Research

Not yet recruiting

Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome (BLINDER)

Nephrotic Syndrome

Italy
Wiltrom Co., Ltd.
Maxis Medical GmbH

Recruiting

Post-Market Study of The Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures

Osteoporotic Vertebral Compression Fractures

Germany
Mario Negri Institute for Pharmacological Research

Recruiting

Outcome of ADPKD With Octreotide LAR (ADPKD648)

Autosomal Dominant Polycystic Kidney

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy (aHUS-iPSC-EC)

Atypical Hemolytic Uremic Syndrome

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Acoustic Analysis of VA Sounds (VAsound)

End Stage Renal Disease | Hemodialysis Access Failure

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

CardioPulmonary Resuscitation With Argon (CPAr) Trial (CPAr)

Cardiac Arrest With Successful Resuscitation | Cardiac Arrest, Out-Of-Hospital

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Health-care Quality in Semi-intensive Care Units

Evaluation | Quality | Semi-intensive Care Unit

Italy
Mario Negri Institute for Pharmacological Research

Withdrawn

LSCI and Thermography in Diabetic Foot Patients Affected by Ulcer(s): (MY-FOOT-B) (MY-FOOT-B)

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Ulcer Foot
Mario Negri Institute for Pharmacological Research

Terminated

CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma (CoQun)

Open Angle Glaucoma

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

NASCITA Italian Birth Cohort Study (NASCITA)

Mental Disorders | Communicable Diseases | Nutrition Disorders | Health Knowledge, Attitudes, Practice | Development, Child | Social Determinants of Health

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Genotype and Susceptibility to COVID-19 (ORIGIN)

Covid19

Italy

Clinical Trials Sponsored by Imaxio

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations